Invention Grant
- Patent Title: Drug-induced activation of the Reelin signaling system
-
Application No.: US16758991Application Date: 2018-10-25
-
Publication No.: US11306059B2Publication Date: 2022-04-19
- Inventor: Edwin John Weeber , Qingyou Li , Melinda Marie Peters , Hana Marie Soueidan
- Applicant: UNIVERSITY OF SOUTH FLORIDA
- Applicant Address: US FL Tampa
- Assignee: UNIVERSITY OF SOUTH FLORIDA
- Current Assignee: UNIVERSITY OF SOUTH FLORIDA
- Current Assignee Address: US FL Tampa
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2018/057609 WO 20181025
- International Announcement: WO2019/084338 WO 20190502
- Main IPC: C07D211/90
- IPC: C07D211/90 ; C07C233/88
Abstract:
Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR.
Public/Granted literature
- US20200347018A1 DRUG-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM Public/Granted day:2020-11-05
Information query
